<DOC>
	<DOC>NCT01861847</DOC>
	<brief_summary>The purpose of this research study is to test the effectiveness of 7-Keto DHEA in reducing symptoms of Post-Traumatic Stress Disorder (PTSD).</brief_summary>
	<brief_title>7-Keto DHEA for the Treatment of PTSD</brief_title>
	<detailed_description>The main purpose of the study is to investigate the possible effect of 7-Keto Dehydroepiandrosterone (7-Keto DHEA) on decreasing Post Traumatic Stress Disorder Symptoms (PTSD) in a Veteran population. The study proposes, based on a 2006 report, that the use of the drug will show significant reduction in overall PTSD symptoms, a decrease in physiological stress response and higher patient-reported quality of life compared to placebo. This is a Phase 2, randomized, double-blind, crossover design with a placebo control. The sponsor for this study is Humanetics Corporation</detailed_description>
	<mesh_term>Dehydroepiandrosterone</mesh_term>
	<criteria>Veteran status and enrolled for care in the Veteran Health Administration Ages 1864 Primary diagnosis of PTSD as assess by the clinician administered PTSD scale and independent clinical mental health evaluation psychosis Dementia Active alcohol and/or substance abuse or dependence Active suicidal or homicidal ideation Medical concerns that would exclude use of 7Keto DHEA</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>